Analyst: Bill Ackman's Zoetis Move Casts Doubt On Allergan Bid

By: via Benzinga
Allergan, Inc.'s (NYSE: AGN) acquisition by Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is looking less likely, in light of a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.